Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 12, Pages 4598-4603
Publisher
Proceedings of the National Academy of Sciences
Online
2012-03-06
DOI
10.1073/pnas.1118104109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Chemokine Receptor CXCR3 Is Degraded following Internalization and Is Replenished at the Cell Surface by De Novo Synthesis of Receptor
- (2014) A. Meiser et al. JOURNAL OF IMMUNOLOGY
- CXCR3 antagonists: Quaternary ammonium salts equipped with biphenyl- and polycycloaliphatic-anchors
- (2011) Maikel Wijtmans et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Subsets of human CD4+ regulatory T cells express the peripheral homing receptor CXCR3
- (2011) André Hoerning et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells
- (2011) Jonathan Sprent et al. NATURE IMMUNOLOGY
- Heterophilic chemokine receptor interactions in chemokine signaling and biology
- (2010) Birgit K. Kramp et al. EXPERIMENTAL CELL RESEARCH
- Anti-chemokine small molecule drugs: a promising future?
- (2010) Amanda EI Proudfoot et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease
- (2010) Sebastian Schroepf et al. INFLAMMATORY BOWEL DISEASES
- Characterization of the Chemokine CXCL11-Heparin Interaction Suggests Two Different Affinities for Glycosaminoglycans
- (2010) India C. Severin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
- (2009) Douglas A. Stewart et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12
- (2009) Graeme O'Boyle et al. FASEB JOURNAL
- T cell extravasation: Demonstration of synergy between activation of CXCR3 and the T cell receptor
- (2009) Peter Newton et al. MOLECULAR IMMUNOLOGY
- Regulatory T-Cell Suppression of CD8+ T-Cell-Mediated Graft-Versus-Host Reaction Requires Their Presence During Priming
- (2009) Xiao-Nong Wang et al. TRANSPLANTATION
- CXCR3 Antagonism Impairs the Development of Donor-Reactive, IFN-γ-Producing Effectors and Prolongs Allograft Survival
- (2009) Joshua M. Rosenblum et al. TRANSPLANTATION
- Non-obese diabetic-recombination activating gene-1 (NOD-Rag 1null) interleukin (IL)-2 receptor common gamma chain (IL 2 rγnull) null mice: a radioresistant model for human lymphohaematopoietic engraftment
- (2008) T. Pearson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients
- (2008) Takuji Iwamoto et al. FEBS Journal
- Technique for Generating Three-Dimensional Alignments of Multiple Ligands from One-Dimensional Alignments
- (2008) Andrei V. Anghelescu et al. Journal of Chemical Information and Modeling
- Orchestrating the orchestrators: chemokines in control of T cell traffic
- (2008) Shannon K Bromley et al. NATURE IMMUNOLOGY
- Chemokine receptor antagonists: overcoming developmental hurdles
- (2008) Richard Horuk NATURE REVIEWS DRUG DISCOVERY
- CXCR3 Antagonist NBI-74330 Attenuates Atherosclerotic Plaque Formation in LDL Receptor–Deficient Mice
- (2007) Eva J.A. van Wanrooij et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started